22 November 2017 - Cancer patients say they are sick of paying for their own survival after an independent report revealed a $682 million "hole" in government funding for lifesaving medicines.
To keep her terminal breast cancer at bay, Auckland woman Lynne Hanson pays $1100 every month for fulvestrant – an unfunded hormone therapy drug – and feels the best she has in years.
But the 60-year-old refuses to remortgage her house to pay for her treatment.